The University of Southampton
University of Southampton Institutional Repository

Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region

Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region
Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region

Background The latest data release from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2023 has enabled us to conduct an updated analysis of the trends and burdens of common metabolic diseases/risk factors from 1990 to 2023 in the Asia-Pacific region. We aimed to highlight disparities across geographic regions, over time, and by sex, while incorporating a predictive assessment of future trends through 2030. Methods We analyzed estimates of disability-adjusted life years (DALYs) and mortality for five common metabolic diseases and risk factors in the Asia-Pacific region (type 2 diabetes mellitus [T2DM], high systolic blood pressure [SBP], high body mass index [BMI], high LDL cholesterol, and metabolic dysfunction-associated steatotic liver disease [MASLD]). We also used Bayesian age-period-cohort (BAPC) models to project disease burdens through 2030. Results In 2023, in Asia-Pacific region, high SBP accounted for the largest burden (~138 million DALYs; 6.27 million deaths), followed by high BMI (~55 million DALYs; 1.33 million deaths), high LDL cholesterol (~53 million DALYs; 2.02 million deaths), T2DM (~49 million DALYs; 1.13 million deaths), and MASLD (~1.26 million DALYs; 47 thousand deaths). From 1990 to 2023, total DALYs increased 1.7- to 3.7- fold, with absolute burdens highest in China, India, and Indonesia, and relative burdens concentrated in Pacific Islands. Projected trends through 2023 suggest that the burden of all metabolic diseases/risk factors, except MASLD, is likely to continue rising, with high SBP remaining the dominant contributor. Conclusion Analysis of the GBD 2023 and 2030 projections show that metabolic diseases/risk factors will remain a persistent challenge for the Asia-Pacific region, with substantial increases in DALYs and mortality. These findings call for coordinated, intensified global actions to address interconnected metabolic conditions and can have positive implications for the United Nations' 2030 health-related goals.

Asia-Pacific region, Burden of disease, Metabolic diseases, Trends
0026-0495
Zhang, Huai
5dbea27e-9def-4a6b-9528-d26381620ee2
Chen, Qin-Fen
362e42a5-7cb3-40d7-81e7-57bc17263a69
Lip, Gregory Y. H.
f957910b-2c7f-465d-ba57-9d98f9dc4054
Tilg, Herbert
c91f3539-28ce-4157-815d-f489dd658795
Valenti, Luca
bd338696-36f8-4ecd-8a30-f4828b3dc204
Byrne, Chris
1370b997-cead-4229-83a7-53301ed2a43c
et al.
Zhang, Huai
5dbea27e-9def-4a6b-9528-d26381620ee2
Chen, Qin-Fen
362e42a5-7cb3-40d7-81e7-57bc17263a69
Lip, Gregory Y. H.
f957910b-2c7f-465d-ba57-9d98f9dc4054
Tilg, Herbert
c91f3539-28ce-4157-815d-f489dd658795
Valenti, Luca
bd338696-36f8-4ecd-8a30-f4828b3dc204
Byrne, Chris
1370b997-cead-4229-83a7-53301ed2a43c

et al. (2026) Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region. Metabolism, 179, [156575]. (doi:10.1016/j.metabol.2026.156575).

Record type: Article

Abstract

Background The latest data release from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2023 has enabled us to conduct an updated analysis of the trends and burdens of common metabolic diseases/risk factors from 1990 to 2023 in the Asia-Pacific region. We aimed to highlight disparities across geographic regions, over time, and by sex, while incorporating a predictive assessment of future trends through 2030. Methods We analyzed estimates of disability-adjusted life years (DALYs) and mortality for five common metabolic diseases and risk factors in the Asia-Pacific region (type 2 diabetes mellitus [T2DM], high systolic blood pressure [SBP], high body mass index [BMI], high LDL cholesterol, and metabolic dysfunction-associated steatotic liver disease [MASLD]). We also used Bayesian age-period-cohort (BAPC) models to project disease burdens through 2030. Results In 2023, in Asia-Pacific region, high SBP accounted for the largest burden (~138 million DALYs; 6.27 million deaths), followed by high BMI (~55 million DALYs; 1.33 million deaths), high LDL cholesterol (~53 million DALYs; 2.02 million deaths), T2DM (~49 million DALYs; 1.13 million deaths), and MASLD (~1.26 million DALYs; 47 thousand deaths). From 1990 to 2023, total DALYs increased 1.7- to 3.7- fold, with absolute burdens highest in China, India, and Indonesia, and relative burdens concentrated in Pacific Islands. Projected trends through 2023 suggest that the burden of all metabolic diseases/risk factors, except MASLD, is likely to continue rising, with high SBP remaining the dominant contributor. Conclusion Analysis of the GBD 2023 and 2030 projections show that metabolic diseases/risk factors will remain a persistent challenge for the Asia-Pacific region, with substantial increases in DALYs and mortality. These findings call for coordinated, intensified global actions to address interconnected metabolic conditions and can have positive implications for the United Nations' 2030 health-related goals.

Text
GBD_metabolic diseases Asia Pacifc_R2_20260114 - Accepted Manuscript
Restricted to Repository staff only until 23 February 2027.
Request a copy
Text
tables 2023 Asia Pacifc_R2_20260214 - Accepted Manuscript
Restricted to Repository staff only until 23 February 2027.
Request a copy
Slideshow
figures - Accepted Manuscript
Restricted to Repository staff only until 23 February 2027.
Request a copy
Text
Supplemental Materials_R2_20260214 - Accepted Manuscript
Restricted to Repository staff only until 23 February 2027.
Request a copy

More information

Accepted/In Press date: 21 February 2026
e-pub ahead of print date: 26 February 2026
Published date: 4 March 2026
Additional Information: Publisher Copyright: © 2026 Elsevier Inc.
Keywords: Asia-Pacific region, Burden of disease, Metabolic diseases, Trends

Identifiers

Local EPrints ID: 510457
URI: http://eprints.soton.ac.uk/id/eprint/510457
ISSN: 0026-0495
PURE UUID: a5f3ee8f-752e-470f-b6a4-f32e54445c1d
ORCID for Chris Byrne: ORCID iD orcid.org/0000-0001-6322-7753

Catalogue record

Date deposited: 31 Mar 2026 17:07
Last modified: 01 Apr 2026 01:36

Export record

Altmetrics

Contributors

Author: Huai Zhang
Author: Qin-Fen Chen
Author: Gregory Y. H. Lip
Author: Herbert Tilg
Author: Luca Valenti
Author: Chris Byrne ORCID iD
Corporate Author: et al.

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×